Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Meiji Yasuda America Inc Increases Holdings in Gilead Sciences, Inc. $GILD - Markets Daily
Gilead Sciences, Inc. $GILD Holdings Decreased by Westpac Banking Corp
First Trust Advisors LP Buys 1,683,586 Shares of Gilead Sciences, Inc. $GILD
Gilead (GILD) Stock Could Still Trade At A Discount Following Its 127% Run
Gilead Sciences, Inc. $GILD Shares Bought by Meiji Yasuda America Inc - Stock Observer
Oslo Pensjonsforsikring AS Makes New $648,000 Investment in Gilead Sciences, Inc. $GILD - Stock Observer
Florida Financial Advisors LLC Lowers Position in Gilead Sciences, Inc. $GILD - Stock Observer
Gilead (GILD) Will Bring New HIV Data And A Merck Regimen To AIDS 2026
Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 | Morningstar
GILD: Once-Weekly Oral HIV Regime Maintains Virologic Suppression At Week 48
Pharmaceutical Stocks Worth Watching - July 21st - Stock Observer
Gilead Sciences' Quarterly Earnings Preview: What You Need to Know
Here Are Tuesday's Top Wall Street Analyst Research Calls: Adobe, Datadog, Five Below, Fortinet, Gilead Sciences, Goldman Sachs, Microsoft, Salesforce, and More
Summit Global Investments Trims Stock Position in Gilead Sciences, Inc. $GILD - Markets Daily
Summit Global Investments Cuts Holdings in Gilead Sciences, Inc. $GILD
Independent Financial Group LLC Takes Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Position Decreased by Convergence Investment Partners LLC
Gilead Sciences (NASDAQ:GILD) Downgraded by Leerink Partners to Market Perform - Daily Political
DJE Kapital AG Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Mosaic chromosomal alterations are suppressed in older adults with HIV
KBC Group NV Has $373.46 Million Stock Position in Gilead Sciences, Inc. $GILD - Zolmax
Pharmaceutical Stocks To Research - July 20th - Daily Political
KBC Group NV Has $373.46 Million Stake in Gilead Sciences, Inc. $GILD
Dimensional Fund Advisors LP Lowers Stock Holdings in Gilead Sciences, Inc. $GILD
FY2026 EPS Forecast for Gilead Sciences Boosted by Analyst
Swiss National Bank Buys 240,800 Shares of Gilead Sciences, Inc. $GILD
SEB Asset Management AB Invests $171.84 Million in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by Financiere des Professionnels Fonds d investissement inc. - Markets Daily
Dorsey Wright & Associates Acquires New Stake in Gilead Sciences, Inc. $GILD - Markets Daily
Swiss National Bank Has $507.45 Million Holdings in Gilead Sciences, Inc. $GILD - Stock Observer
Assetmark Inc. Cuts Stock Position in Gilead Sciences, Inc. $GILD
Jennison Associates LLC Has $176.24 Million Stake in Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Stock Tops 3 GARP Picks Trading On More Measured Valuations
Gilead Sciences synthesizes new KRAS mutant inhibitors
Jag Capital Management LLC Increases Stake in Gilead Sciences, Inc. $GILD
Sigma Planning Corp Sells 7,783 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Bought by D.A. Davidson & CO.
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia
Is Gilead Sciences (GILD) Fully Valued Following Mixed Earnings And A Full Year EPS Miss?
Sanctuary Advisors LLC Cuts Stock Holdings in Gilead Sciences, Inc. $GILD
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial
Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?
Should Gilead's Revenue Beat but Softer EPS Outlook Require Action From Gilead Sciences (GILD) Investors?
Diversify Wealth Management LLC Acquires 5,072 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Bleakley Financial Group LLC Acquires 24,649 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Calamos Advisors LLC Raises Stock Holdings in Gilead Sciences, Inc. $GILD
J. Safra Sarasin Holding AG Lowers Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Rating of "Moderate Buy" by Analysts - Zolmax
Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Brokerages
AMF Tjanstepension AB Buys 17,302 Shares of Gilead Sciences, Inc. $GILD
Procyon Advisors LLC Increases Stock Position in Gilead Sciences, Inc. $GILD - Stock Observer
Teachers Retirement System of The State of Kentucky Has $85.62 Million Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences (NASDAQ:GILD) Raised to Buy at Wall Street Zen
Gilead Sciences (NASDAQ:GILD) Rating Increased to Buy at Wall Street Zen
Fifth Third Bancorp Purchases 226,510 Shares of Gilead Sciences, Inc. $GILD
Wells Fargo Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)
Candriam S.C.A. Has $232.79 Million Holdings in Gilead Sciences, Inc. $GILD
Conning Inc. Decreases Position in Gilead Sciences, Inc. $GILD
Gilead Sciences Down Over 4%, on Pace for Largest Percent Decrease Since July 2025 - Data Talk | Morningstar
Ibex Wealth Advisors Has $2.14 Million Holdings in Gilead Sciences, Inc. $GILD
Gilead (GILD) Stock Looks Below Fair Value But Earnings Already Look Priced In
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Gilead Sciences, Inc. $GILD - Zolmax
Sumitomo Mitsui Trust Group Inc. Decreases Position in Gilead Sciences, Inc. $GILD - Markets Daily
Resona Asset Management Co. Ltd. Has $58.67 Million Stake in Gilead Sciences, Inc. $GILD - Stock Observer
Morgan Stanley Keeps Buy Rating on Gilead (GILD)
Pharmaceutical Stocks To Watch Now - July 8th - Markets Daily
Gilead Sciences (NASDAQ:GILD) Price Target Cut to $166.00 by Analysts at Morgan Stanley
Gilead Sciences (GILD) Could Be 53% Below Fair Value After Trodelvy Approval
O Domhnaill Enterprises Inc. Makes New Investment in Gilead Sciences, Inc. $GILD - Zolmax
15,198 Shares in Gilead Sciences, Inc. $GILD Acquired by O Domhnaill Enterprises Inc.
Gilead Sciences (NASDAQ:GILD) Given New $156.00 Price Target at Truist Financial
Swedbank AB Has $334.21 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial
Gilead Sciences' (GILD) Overweight Rating Reaffirmed at Cantor Fitzgerald
Here Are Monday's Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More
Raleigh Capital Management Inc. Sells 6,614 Shares of Gilead Sciences, Inc. $GILD
Experimental Ebola trial begins in Congo as death toll tops 500
Should First-Line Trodelvy Breast Cancer Approvals Reshape the Gilead Sciences (GILD) Investment Narrative?
Is Gilead (GILD) One of the Most Undervalued NASDAQ Stocks to Buy Right Now?
Gilead Sciences, Inc. $GILD Shares Bought by Kepler Cheuvreux Suisse SA
Berger Financial Group Inc Trims Stock Position in Gilead Sciences, Inc. $GILD
HB Wealth Management LLC Acquires 5,516 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Rep. Jared Moskowitz Purchases Gilead Sciences, Inc. (NASDAQ:GILD) Stock - Daily Political
Top Pharmaceutical Stocks To Follow Today - July 4th
Rep. Jared Moskowitz Buys Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
QRG Capital Management Inc. Sells 15,139 Shares of Gilead Sciences, Inc. $GILD - Markets Daily
QRG Capital Management Inc. Trims Stake in Gilead Sciences, Inc. $GILD - Zolmax
Gilead News
Alphabet (GOOGL) Stock Forecast 2026–2030: Where Could Google Stock Go as AI Spending Accelerates?
US Dollar Forecast 2026 (H2 Outlook): Will the USD Stay Strong Through Year-End?
Nvidia Stock Prediction 2030: Will It Hit a $10 Trillion Market Cap?
Week Ahead: The PBoC and the ECB are set to deliver interest rates
Latest news
Show more
Gold Price Today, July 23: Gold Holds Above $4,100 as Oil Rally Limits Gains
Fed Rate Decision Preview: Will the Fed Raise Rates at the July 29, 2026 Meeting?
Crude Oil Prices Rise 2% to Six-Week High as US-Iran Tensions Escalate
Bitcoin Price Forecast: BTC Slips as Rising Oil Prices Renew Inflation Concerns
KOSPI Jumps More Than 3% as Alphabet’s $200 Billion AI Plan Lifts Chip Stocks
Tesla 2026 Q2 Earnings: Revenue Surges 26% as AI Investments Weigh on Profits and Cash Flow
